Output details
15 - General Engineering
University College London
Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells.
This was the first paper published describing the functionalisation – via bioengineered hydrogen-bond linkers that successfully retained the receptor-seeking antibody presentation – of magnetic nanoparticles for targeting cancer cells in the human body. This was a key enabling step toward an embodiment of my vision of a combined diagnostic (through MRI) and therapeutic (through magnetic hyperthermia) approach to cancer treatment. It formed the basis of a £4.9M EU project, now under way, that has as its primary goal to reach clinical trials in the thermal treatment of glioblastoma (an aggressive form of brain cancer) by 2016